Study Seeks to Prevent Cancer and Extend Quality of Life for Women at Increased Genetic Risk of Ovarian Cancer

Advocacy Groups | <b>FORCE</b>

The trial is testing if removing the fallopian tubes before menopause prevents ovarian cancer.

Researchers in gynecologic oncology have begun testing a promising surgery for premenopausal women at high genetic risk for ovarian cancer that avoids early menopause and may prevent these malignancies from developing. Studies have shown that most ovarian cancers actually begin to grow from cancer cells that developed in the fallopian tubes. This trial is testing if removing the fallopian tubes before menopause prevents ovarian cancer.

In a large-scale clinical trial sponsored by the National Cancer Institute, researchers hope to determine whether this approach is equivalent to the prevailing surgical standard of care for women testing positive for mutations in their BRCA1 genes: oophorectomy, or the removal of both ovaries and the fallopian tubes, before the age of 40 years.

Read the full blog post that was originally published by the National Cancer Institute.

https://www.facingourrisk.org/blog/study-seeks-to-prevent-cancer-and-extend-quality-of-life-for-women-at-increased-genetic-risk-of-ovarian-cancer?utm_source=CURE&utm_medium=referral&utm_campaign=organic_social_